Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 7, 2011, Pages 593-599

  Kanbak, Meral ^a   Oc, Bahar ^b   Salman, Mehmet A ^c   Ocal, Turgay ^a   Oc, Mehmet ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c GÜVEN HOSPITAL   (Turkey)

Author keywords

antithrombin III; blood coagulation tests; cardiac surgery; fresh frozen plasma; heparin; nitroglycerin

Indexed keywords

ANTITHROMBIN III CONCENTRATE; FIBRINOGEN; FRESH FROZEN PLASMA; GLYCERYL TRINITRATE; HEPARIN; PROTAMINE SULFATE;

ADULT; ANESTHESIA; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SENSITIVITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PEROPERATIVE CARE; PRIORITY JOURNAL;

AGED; ANTICOAGULANTS; ANTITHROMBIN III; BLOOD COAGULATION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FIBRINOGEN; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PARTIAL THROMBOPLASTIN TIME; PLASMA; VASODILATOR AGENTS;

EID: 80053605878     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834a0478     Document Type: Article

References (26)

1. Kal JE, Vergroesen I, Van Wezel HB. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilatation in patients with coronary artery disease. Anesth Analg 1999; 88:271-278. (Pubitemid 29070182)
2. Becker RC, Corrao JM, Bovill EG, Gore JM, Baker SP, Miller ML, et al. Intravenous nitroglycerine-induced heparin resistance: a qualitative antithrombin III abnormality. Am Heart J 1990; 119:1254-1261. (Pubitemid 20215608)
3. Habbab MA, Haft JI. Heparin resistance induced by intravenous nitroglycerin. Arch Intern Med 1987; 147:857-860.
4. Gayoso JM. 5-year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements. J Extra Corpor Technol 1999; 31:184-190. (Pubitemid 30176833)
5. Berk SI, Grunwald A, Pal S, Bodenheimer MM. Effect of intravenous nitroglycerin on heparin dosage requirements in coronary artery disease. Am J Cardiol 1993; 72:393-396. (Pubitemid 23238420)
6. Kanbak M, Ezer F, Dal D, Ocal T, Kahraman S, Aypar U. Does intraoperative nitroglycerin infusion have an effect on heparin anticoagulation and AT III activity? T Klin J Med Res 1998; 16:88-92.
7. Lepor NE, Amin DK, Berberian L, Shan PK. Does nitroglycerin induce heparin resistance? Clin Cardiol 1989; 12:432-434. (Pubitemid 19201457)
8. Lichtenthal PR, Rossi EC, Louis G, Rehnberg KA, Wade LD, Michaelis LL, et al. Dose-related prolongation of bleeding time by intravenous nitroglycerin. Anesth Analg 1985; 64:30-33. (Pubitemid 15178837)
9. Barnette RE, Shupak RC, Pontius J, Rao AK. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass. Anesth Analg 1988; 67:57-60.
10. Sabbagh AH, Chung GKT, Shuttleworth P, Applegate BJ, Gabrhel W. Fresh frozen plasma: a solution to heparin resistance during cardiopulmonary bypass. Ann Thorac Surg 1984; 37:466-468. (Pubitemid 14077464)
11. Lemmer JH, Despotis GJ. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2002; 123:213-217. (Pubitemid 34127106)
12. Williams MR, D'Ambra AB, Beck JR, Spanier TB, Morales DLS, Helman DN, et al. A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg 2000; 70:873-877.
13. Irani MS. Antithrombin concentrates in heparin-resistant cardiopulmonary bypass patients. Clin Appl Thrombosis Hemostasis 1996; 2:103-106. (Pubitemid 126699851)
14. Conley JC, Plunkett PF. Antithrombin III in cardiac surgery: an outcome study. J Extra Corpor Technol 1998; 30:178-183. (Pubitemid 29152673)
15. Sonzogni V, Bellavita OP, Carrara B, Cossolini M, Ferri F, Fabretti F, et al. The effect of antithrombin III concentration during cardiopulmonary surgery. Minerva Anestesiol 2000; 66:17-23.
16. Rossi M, Martinelli L, Storti S, Corrado M, Marra R, Varano C, et al. The role of antithrombin III in the perioperative management of the patient with unstable angina. Ann Thorac Surg 1999; 68:2231-2236. (Pubitemid 30027855)
17. Young JA, Kisker CT, Doty DB. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann Thorac Surg 1978; 26:231-240. (Pubitemid 9014677)
18. Schoenenberger RA, Ménat L, Weiss P, Marbet GA, Ritz R. Absence of nitroglycerin-induced resistance in healthy volunteers. Eur Heart J 1992; 13:411-414.
19. Gonzalez ER, Jones HD, Graham S, Elswick RK. Assessment of the drug interaction between intravenous nitroglycerin and heparin. Ann Pharmacother 1992; 26:1512-1514.
20. Brach MJ, More RS, Hubner PJ, Gershlic F. The effect of low dose nitroglycerin on plasma heparin concentration and activated partial thromboplastin times. Blood Coagul Fibrinolysis 1993; 4:183-186. (Pubitemid 23064939)
21. Koster A, Fischer T, Gruendel M, Mappes A, Kuebler WM, Bauer M, et al. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation. J Cardiovasc Anesth 2003; 17:171-175. (Pubitemid 36457470)
22. Levy JH, Montes F, Szlam F, Hillyer CD. The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy. Anesth Analg 2000; 90:1076-1079. (Pubitemid 30253452)
23. Despotis GJ, Levine V, Joist JH, Joiner-Maier D, Spitznagel E. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation. Anesth Analg 1997; 85:498-506. (Pubitemid 27381298)
24. Kanbak M. The treatment of heparin resistance with antithrombin III in cardiac surgery. Can J Anesth 1999; 46:581-585. (Pubitemid 29327686)
25. Slaughter TF, Mark JB, El-Moalem H, Hayward KA, Hilton AK, Hodgins LP, et al. Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation. Blood Coagul Fibrinolysis 2001; 12:25-31. (Pubitemid 32150248)
26. Kasper SM, Giesecke T, Limpers P, Sabatowski R, Mehlborn U, Diefenbach C. Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery. Anesthesiology 2001; 95:81-86. (Pubitemid 32623000)